BC
NVCR icon

Brinker Capital’s NovoCure NVCR Stock Holding History

Brinker Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$612K Sell
10,326
-1,642
-14% -$108K 0.02% 664
2020
Q1 		$806K Buy
11,968
+3,574
+43% +$282K 0.03% 495
2019
Q4 		$707K Buy
8,394
+4,519
+117% +$365K 0.02% 617
2019
Q3 		$290K Buy
+3,875
New +$310K 0.01% 828

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

Brinker Capital's NVCR Position: Q2 2020 in Review

Brinker Capital reduced its NovoCure (NVCR) stake by 14% in Q2 2020, selling an estimated $108K and leaving 10,326 shares worth $612K. The position accounts for 0.02% of the portfolio, ranked #664.

Brinker Capital first reported a position in NVCR in Q3 2019 and has held it in 4 quarters since. The position peaked at $806K in Q1 2020. 264 funds tracked by Wall St. Rank hold NVCR as of Q2 2020.

  • Brinker Capital held 10,326 shares of NovoCure worth $612K as of Q2 2020.
  • Brinker Capital sold 1,642 NovoCure shares in Q2 2020, an estimated $108K.
  • NovoCure made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #664 holding.
  • Brinker Capital first reported a position in NovoCure in Q3 2019 and has held it in 4 quarters since.
  • Brinker Capital's NovoCure position peaked at $806K in Q1 2020.
  • 264 funds tracked by Wall St. Rank held NovoCure as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.